In-Lab Upfront Use of Tirofiban May Reduce the Occurrence of No-Reflow During Primary Percutaneous Coronary Intervention. A Pilot Randomized Study

BACKGROUND: Despite successful opening of culprit coronary artery, myocardial reperfusion does not always follows primary percutaneous coronary intervention (PPCI). Glycoprotein IIb/IIIa inhibitors are used in the treatment of no-reflow (NR), but their role to prevent it is unproven. OBJECTIVE: To e...

Descripción completa

Detalles Bibliográficos
Autores principales: Lago, Igor Matos, Novaes, Gustavo Caires, Badran, André Vannucchi, Pavão, Rafael Brolio, Barbosa, Ricardo, de Figueiredo, Geraldo Luiz, Lima, Moysés de Oliveira, Haddad, Jorge Luiz, Schmidt, André, Marin, José Antônio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Cardiologia - SBC 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137384/
https://www.ncbi.nlm.nih.gov/pubmed/27982267
http://dx.doi.org/10.5935/abc.20160149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137384/
https://www.ncbi.nlm.nih.gov/pubmed/27982267
http://dx.doi.org/10.5935/abc.20160149

Ejemplares similares